MEDSAFE Grants Marketing Approval For Abraxane: Abraxis, Specialised Therapeutics
Abraxane is a solvent-free chemotherapy treatment option for metastatic breast cancer which was developed using Abraxis BioScience’s proprietary nab technology platform. Abraxis BioScience said that it has granted
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.